UNICHEMLABNSEUnichem Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 20 Apr · 17:27 IST

IPCA Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.8%1-day move
₹346.55
prior close
₹345.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+0.8+0.3+0.5+6.8+10.7+7.3+8.7+6.5+12.3+4.5+7.8+29.3+68.9
Up moveDown movePending
AI summary

Ipca Laboratories Limited, as promoters of Unichem Laboratories Limited, has filed a declaration with NSE and BSE confirming that they have not created any encumbrance (pledge or lien) on their equity shares in Unichem Laboratories for the financial year ended March 31, 2026. This is a mandatory regulatory disclosure under SEBI Takeovers Regulations. The annexure lists Ipca Laboratories as the sole promoter and person acting in concert (PAC) without any PAN details provided. The declaration is signed by Harish Kamath, Corporate Counsel and Company Secretary of Ipca Laboratories.

Likely market impact

This is a positive disclosure for Unichem shareholders as it confirms promoters have not pledged their shares, which means their holding is not leveraged or at risk of being sold in the event of a loan default. This typically signals promoter confidence in the company's fundamentals.